261 related articles for article (PubMed ID: 30465653)
1. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ
Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653
[TBL] [Abstract][Full Text] [Related]
2. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
[TBL] [Abstract][Full Text] [Related]
3. Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia.
Lee H; Park JY; Lee T; Lee YJ; Lim HJ; Park JS; Yoon HI; Lee JH; Lee CT; Cho YJ
Korean J Intern Med; 2016 May; 31(3):525-34. PubMed ID: 26968189
[TBL] [Abstract][Full Text] [Related]
4. Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes.
Hyun H; Song JY; Yoon JG; Seong H; Noh JY; Cheong HJ; Kim WJ
PLoS One; 2022; 17(6):e0270261. PubMed ID: 35767562
[TBL] [Abstract][Full Text] [Related]
5. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
[TBL] [Abstract][Full Text] [Related]
6. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
Webb BJ; Dascomb K; Stenehjem E; Dean N
Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
[TBL] [Abstract][Full Text] [Related]
7. Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.
Falcone M; Venditti M; Shindo Y; Kollef MH
Int J Infect Dis; 2011 Aug; 15(8):e545-50. PubMed ID: 21616695
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.
Shindo Y; Ito R; Kobayashi D; Ando M; Ichikawa M; Shiraki A; Goto Y; Fukui Y; Iwaki M; Okumura J; Yamaguchi I; Yagi T; Tanikawa Y; Sugino Y; Shindoh J; Ogasawara T; Nomura F; Saka H; Yamamoto M; Taniguchi H; Suzuki R; Saito H; Kawamura T; Hasegawa Y
Am J Respir Crit Care Med; 2013 Oct; 188(8):985-95. PubMed ID: 23855620
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
10. [The comparison of patients with hospitalized health-care-associated pneumonia to community-acquired pneumonia].
Taşbakan MS; Bacakoğlu F; Başoğlu OK; Gürgün A; Başarik B; Citim Tuncel S; Sayiner A
Tuberk Toraks; 2011; 59(4):348-54. PubMed ID: 22233304
[TBL] [Abstract][Full Text] [Related]
11. Timing of antibiotic administration and outcomes of hospitalized patients with community-acquired and healthcare-associated pneumonia.
Simonetti A; Viasus D; Garcia-Vidal C; Adamuz J; Roset A; Manresa F; Dorca J; Gudiol F; Carratalà J
Clin Microbiol Infect; 2012 Nov; 18(11):1149-55. PubMed ID: 22115052
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia.
Gross AE; Van Schooneveld TC; Olsen KM; Rupp ME; Bui TH; Forsung E; Kalil AC
Antimicrob Agents Chemother; 2014 Sep; 58(9):5262-8. PubMed ID: 24957843
[TBL] [Abstract][Full Text] [Related]
13. The difference in clinical presentations between healthcare-associated and community-acquired pneumonia in university-affiliated hospital in Korea.
Jeon EJ; Cho SG; Shin JW; Kim JY; Park IW; Choi BW; Choi JC
Yonsei Med J; 2011 Mar; 52(2):282-7. PubMed ID: 21319347
[TBL] [Abstract][Full Text] [Related]
14. The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).
Kaku N; Yanagihara K; Morinaga Y; Izumikawa K; Nagashima S; Kakeya H; Yamamoto Y; Fukuda M; Takatani H; Fukuda M; Hashiguchi K; Kohno S
J Infect Chemother; 2013 Feb; 19(1):70-6. PubMed ID: 22850821
[TBL] [Abstract][Full Text] [Related]
15. A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
Maruyama T; Fujisawa T; Ishida T; Ito A; Oyamada Y; Fujimoto K; Yoshida M; Maeda H; Miyashita N; Nagai H; Imamura Y; Shime N; Suzuki S; Amishima M; Higa F; Kobayashi H; Suga S; Tsutsui K; Kohno S; Brito V; Niederman MS
Clin Infect Dis; 2019 Mar; 68(7):1080-1088. PubMed ID: 30084884
[TBL] [Abstract][Full Text] [Related]
16. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
17. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital.
Shindo Y; Sato S; Maruyama E; Ohashi T; Ogawa M; Hashimoto N; Imaizumi K; Sato T; Hasegawa Y
Chest; 2009 Mar; 135(3):633-640. PubMed ID: 19017892
[TBL] [Abstract][Full Text] [Related]
18. Treatment Trends and Outcomes in Healthcare-Associated Pneumonia.
Haessler S; Lagu T; Lindenauer PK; Skiest DJ; Priya A; Pekow PS; Zilberberg MD; Higgins TL; Rothberg MB
J Hosp Med; 2017 Nov; 12(11):886-891. PubMed ID: 29091975
[TBL] [Abstract][Full Text] [Related]
19. Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study.
Bjarnason A; Asgeirsson H; Baldursson O; Kristinsson KG; Gottfredsson M
Infect Dis (Lond); 2015 Mar; 47(3):130-6. PubMed ID: 25664503
[TBL] [Abstract][Full Text] [Related]
20. Validation of a scoring tool to predict drug-resistant pathogens in hospitalised pneumonia patients.
Park SC; Kim EY; Kang YA; Park MS; Kim YS; Kim SK; Chang J; Jung JY
Int J Tuberc Lung Dis; 2013 May; 17(5):704-9. PubMed ID: 23575340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
